Ensuring Access to Essential Drugs Act

Bill: 119-hr-1922
Sponsor: full_name: Rep. Garbarino, Andrew R. [R-NY-2]
Introduced: 2025-03-06
Policy area: Health
Latest action: action_date: 2025-03-06
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:

tv_txt: I 119th CONGRESS 1st Session H. R. 1922 IN THE HOUSE OF REPRESENTATIVES March 6, 2025 Mr. Garbarino (for himself, Mrs. Harshbarger , and Mr. Suozzi ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

1. Short title This Act may be cited as the Ensuring Access to Essential Drugs Act . 2. Exempting certain drugs from the part D manufacturer discount program under the Medicare program Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended— (1) in subparagraph (A), by striking and at the end; (2) in subparagraph (B), by striking the period and inserting ; and ; and (3) by adding at the end the following new subparagraph: (C) does not include an orally administered drug— (i) for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and (ii) that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services. .